ASX News Health Care Leukaemia patient shows complete response in Chimeric Therapeutics’ latest trial Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest… 2 mins07 October 2024 11:17 (AEDT)